Our approach

Responsibility Begins with Quality.

Careful sourcing, fit-for-purpose documentation and responsible distribution practices are central to how we approach pharmaceutical trading.

A considered standard

Quality is a shared responsibility.

We approach quality through attention to the products and partners in each supply relationship, alongside the business registrations and responsibilities relevant to trading.

The credentials of a product’s manufacturer are evaluated separately from Balajee Pharmaceuticals’ business registrations. Product and manufacturer requirements depend on the particular product, transaction and market.

Transparency matters.
No WHO-GMP, manufacturing, ISO or international regulatory approval is claimed for Balajee Pharmaceuticals on this website. Registration identifiers and personal details are not published here.

How we think about compliance

Good practice, made visible in the details.

Our business approach includes attention to the applicable requirements that govern pharmaceutical trading and distribution.

01

Drug sale licences & GST registration

Company records document drug sale licences for the trading premises and a GST registration associated with Balajee Pharmaceuticals. The GSTIN, licence identifiers and personal details are not published on this website.

02

Responsible sourcing

Supplier and product sourcing conversations are approached with care and appropriate attention to product and manufacturer credentials.

03

Documentation

Documentation relevant to supply relationships and transactions is an important part of responsible distribution.

04

Product traceability

Traceability information is considered within the records and documentation applicable to products and supply transactions.

05

Responsible distribution

We recognise the importance of handling and distribution practices that reflect applicable requirements and product needs.

06

Market-specific requirements

Any future supply into new or international markets would require assessment of destination-specific regulatory expectations.

Separate evaluations

Business registrations are not a proxy for manufacturer credentials.

Drug sale licences and GST registration relate to the trading business. They do not certify a product or its manufacturer, or replace product-specific or destination-market requirements.

Product sourcing and manufacturer credentials are evaluated separately. Any proposed supply arrangement is subject to the applicable product documentation, authorisations, registrations and regulations for the relevant market.

Questions about a supply relationship?

Let’s discuss the relevant product, documentation and market context.

Contact us ↗